Medical Care
Global Neuroscience Antibodies and Assays Technology Market Research Report 2025
- Mar 11, 25
- ID: 73610
- Pages: 81
- Figures: 81
- Views: 20
The global market for Neuroscience Antibodies and Assays Technology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Neuroscience antibodies and assays technology refers to the specialized tools and techniques used in neuroscience research to study and analyze proteins, biomolecules, and cellular processes in the nervous system. These technologies play a crucial role in understanding the complexities of the brain and its functions, including neuronal communication, synaptic signaling, and the underlying molecular mechanisms of neurological diseases and disorders.
The global market for neuroscience antibodies and assays technology has been witnessing substantial growth due to the increasing research activities in neuroscience, the rising prevalence of neurological disorders, and the advancements in life science technologies. Neuroscience antibodies and assays play a crucial role in understanding the complexities of the nervous system and exploring potential therapeutic targets for neurological diseases. The market for neuroscience antibodies and assays technology is significant in regions with strong research and healthcare infrastructures. North America, including the United States, has been a major contributor to the market due to its large base of research institutions and pharmaceutical companies focused on neuroscience. Europe and Asia-Pacific regions have also witnessed substantial growth in neuroscience research, driving the demand for neuroscience antibodies and assays technology.
This report aims to provide a comprehensive presentation of the global market for Neuroscience Antibodies and Assays Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroscience Antibodies and Assays Technology.
The Neuroscience Antibodies and Assays Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuroscience Antibodies and Assays Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuroscience Antibodies and Assays Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
BioLegend
Siemens
Bio-Rad
Genscript Biotech
Rockland Immunochemicals
Cell Signaling Technology
Merck
Tecan Group
Santa Cruz Biotechnology
Thermo Fisher Scientific
Enzo Life Sciences
Segment by Type
Molecular Diagnostics
Clinical Chemistry
Immunoassay
Immunochemistry
Others
Segment by Application
Hospitals
Diagnostics Center
Pharmaceutical and Biotechnology Company
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuroscience Antibodies and Assays Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Neuroscience antibodies and assays technology refers to the specialized tools and techniques used in neuroscience research to study and analyze proteins, biomolecules, and cellular processes in the nervous system. These technologies play a crucial role in understanding the complexities of the brain and its functions, including neuronal communication, synaptic signaling, and the underlying molecular mechanisms of neurological diseases and disorders.
The global market for neuroscience antibodies and assays technology has been witnessing substantial growth due to the increasing research activities in neuroscience, the rising prevalence of neurological disorders, and the advancements in life science technologies. Neuroscience antibodies and assays play a crucial role in understanding the complexities of the nervous system and exploring potential therapeutic targets for neurological diseases. The market for neuroscience antibodies and assays technology is significant in regions with strong research and healthcare infrastructures. North America, including the United States, has been a major contributor to the market due to its large base of research institutions and pharmaceutical companies focused on neuroscience. Europe and Asia-Pacific regions have also witnessed substantial growth in neuroscience research, driving the demand for neuroscience antibodies and assays technology.
This report aims to provide a comprehensive presentation of the global market for Neuroscience Antibodies and Assays Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroscience Antibodies and Assays Technology.
The Neuroscience Antibodies and Assays Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuroscience Antibodies and Assays Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuroscience Antibodies and Assays Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
BioLegend
Siemens
Bio-Rad
Genscript Biotech
Rockland Immunochemicals
Cell Signaling Technology
Merck
Tecan Group
Santa Cruz Biotechnology
Thermo Fisher Scientific
Enzo Life Sciences
Segment by Type
Molecular Diagnostics
Clinical Chemistry
Immunoassay
Immunochemistry
Others
Segment by Application
Hospitals
Diagnostics Center
Pharmaceutical and Biotechnology Company
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuroscience Antibodies and Assays Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Diagnostics
1.2.3 Clinical Chemistry
1.2.4 Immunoassay
1.2.5 Immunochemistry
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neuroscience Antibodies and Assays Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostics Center
1.3.4 Pharmaceutical and Biotechnology Company
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuroscience Antibodies and Assays Technology Market Perspective (2020-2031)
2.2 Global Neuroscience Antibodies and Assays Technology Growth Trends by Region
2.2.1 Global Neuroscience Antibodies and Assays Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neuroscience Antibodies and Assays Technology Historic Market Size by Region (2020-2025)
2.2.3 Neuroscience Antibodies and Assays Technology Forecasted Market Size by Region (2026-2031)
2.3 Neuroscience Antibodies and Assays Technology Market Dynamics
2.3.1 Neuroscience Antibodies and Assays Technology Industry Trends
2.3.2 Neuroscience Antibodies and Assays Technology Market Drivers
2.3.3 Neuroscience Antibodies and Assays Technology Market Challenges
2.3.4 Neuroscience Antibodies and Assays Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroscience Antibodies and Assays Technology Players by Revenue
3.1.1 Global Top Neuroscience Antibodies and Assays Technology Players by Revenue (2020-2025)
3.1.2 Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Players (2020-2025)
3.2 Global Neuroscience Antibodies and Assays Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neuroscience Antibodies and Assays Technology Revenue
3.4 Global Neuroscience Antibodies and Assays Technology Market Concentration Ratio
3.4.1 Global Neuroscience Antibodies and Assays Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroscience Antibodies and Assays Technology Revenue in 2024
3.5 Global Key Players of Neuroscience Antibodies and Assays Technology Head office and Area Served
3.6 Global Key Players of Neuroscience Antibodies and Assays Technology, Product and Application
3.7 Global Key Players of Neuroscience Antibodies and Assays Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroscience Antibodies and Assays Technology Breakdown Data by Type
4.1 Global Neuroscience Antibodies and Assays Technology Historic Market Size by Type (2020-2025)
4.2 Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Type (2026-2031)
5 Neuroscience Antibodies and Assays Technology Breakdown Data by Application
5.1 Global Neuroscience Antibodies and Assays Technology Historic Market Size by Application (2020-2025)
5.2 Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neuroscience Antibodies and Assays Technology Market Size (2020-2031)
6.2 North America Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025)
6.4 North America Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuroscience Antibodies and Assays Technology Market Size (2020-2031)
7.2 Europe Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025)
7.4 Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size (2020-2031)
8.2 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuroscience Antibodies and Assays Technology Market Size (2020-2031)
9.2 Latin America Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025)
9.4 Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size (2020-2031)
10.2 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Neuroscience Antibodies and Assays Technology Introduction
11.1.4 Abcam Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.1.5 Abcam Recent Development
11.2 BioLegend
11.2.1 BioLegend Company Details
11.2.2 BioLegend Business Overview
11.2.3 BioLegend Neuroscience Antibodies and Assays Technology Introduction
11.2.4 BioLegend Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.2.5 BioLegend Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Neuroscience Antibodies and Assays Technology Introduction
11.3.4 Siemens Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.3.5 Siemens Recent Development
11.4 Bio-Rad
11.4.1 Bio-Rad Company Details
11.4.2 Bio-Rad Business Overview
11.4.3 Bio-Rad Neuroscience Antibodies and Assays Technology Introduction
11.4.4 Bio-Rad Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.4.5 Bio-Rad Recent Development
11.5 Genscript Biotech
11.5.1 Genscript Biotech Company Details
11.5.2 Genscript Biotech Business Overview
11.5.3 Genscript Biotech Neuroscience Antibodies and Assays Technology Introduction
11.5.4 Genscript Biotech Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.5.5 Genscript Biotech Recent Development
11.6 Rockland Immunochemicals
11.6.1 Rockland Immunochemicals Company Details
11.6.2 Rockland Immunochemicals Business Overview
11.6.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Technology Introduction
11.6.4 Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.6.5 Rockland Immunochemicals Recent Development
11.7 Cell Signaling Technology
11.7.1 Cell Signaling Technology Company Details
11.7.2 Cell Signaling Technology Business Overview
11.7.3 Cell Signaling Technology Neuroscience Antibodies and Assays Technology Introduction
11.7.4 Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.7.5 Cell Signaling Technology Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Neuroscience Antibodies and Assays Technology Introduction
11.8.4 Merck Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.8.5 Merck Recent Development
11.9 Tecan Group
11.9.1 Tecan Group Company Details
11.9.2 Tecan Group Business Overview
11.9.3 Tecan Group Neuroscience Antibodies and Assays Technology Introduction
11.9.4 Tecan Group Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.9.5 Tecan Group Recent Development
11.10 Santa Cruz Biotechnology
11.10.1 Santa Cruz Biotechnology Company Details
11.10.2 Santa Cruz Biotechnology Business Overview
11.10.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Technology Introduction
11.10.4 Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.10.5 Santa Cruz Biotechnology Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Neuroscience Antibodies and Assays Technology Introduction
11.11.4 Thermo Fisher Scientific Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Enzo Life Sciences
11.12.1 Enzo Life Sciences Company Details
11.12.2 Enzo Life Sciences Business Overview
11.12.3 Enzo Life Sciences Neuroscience Antibodies and Assays Technology Introduction
11.12.4 Enzo Life Sciences Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.12.5 Enzo Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Diagnostics
1.2.3 Clinical Chemistry
1.2.4 Immunoassay
1.2.5 Immunochemistry
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neuroscience Antibodies and Assays Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostics Center
1.3.4 Pharmaceutical and Biotechnology Company
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuroscience Antibodies and Assays Technology Market Perspective (2020-2031)
2.2 Global Neuroscience Antibodies and Assays Technology Growth Trends by Region
2.2.1 Global Neuroscience Antibodies and Assays Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neuroscience Antibodies and Assays Technology Historic Market Size by Region (2020-2025)
2.2.3 Neuroscience Antibodies and Assays Technology Forecasted Market Size by Region (2026-2031)
2.3 Neuroscience Antibodies and Assays Technology Market Dynamics
2.3.1 Neuroscience Antibodies and Assays Technology Industry Trends
2.3.2 Neuroscience Antibodies and Assays Technology Market Drivers
2.3.3 Neuroscience Antibodies and Assays Technology Market Challenges
2.3.4 Neuroscience Antibodies and Assays Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroscience Antibodies and Assays Technology Players by Revenue
3.1.1 Global Top Neuroscience Antibodies and Assays Technology Players by Revenue (2020-2025)
3.1.2 Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Players (2020-2025)
3.2 Global Neuroscience Antibodies and Assays Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neuroscience Antibodies and Assays Technology Revenue
3.4 Global Neuroscience Antibodies and Assays Technology Market Concentration Ratio
3.4.1 Global Neuroscience Antibodies and Assays Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroscience Antibodies and Assays Technology Revenue in 2024
3.5 Global Key Players of Neuroscience Antibodies and Assays Technology Head office and Area Served
3.6 Global Key Players of Neuroscience Antibodies and Assays Technology, Product and Application
3.7 Global Key Players of Neuroscience Antibodies and Assays Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroscience Antibodies and Assays Technology Breakdown Data by Type
4.1 Global Neuroscience Antibodies and Assays Technology Historic Market Size by Type (2020-2025)
4.2 Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Type (2026-2031)
5 Neuroscience Antibodies and Assays Technology Breakdown Data by Application
5.1 Global Neuroscience Antibodies and Assays Technology Historic Market Size by Application (2020-2025)
5.2 Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neuroscience Antibodies and Assays Technology Market Size (2020-2031)
6.2 North America Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025)
6.4 North America Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuroscience Antibodies and Assays Technology Market Size (2020-2031)
7.2 Europe Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025)
7.4 Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size (2020-2031)
8.2 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuroscience Antibodies and Assays Technology Market Size (2020-2031)
9.2 Latin America Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025)
9.4 Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size (2020-2031)
10.2 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Neuroscience Antibodies and Assays Technology Introduction
11.1.4 Abcam Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.1.5 Abcam Recent Development
11.2 BioLegend
11.2.1 BioLegend Company Details
11.2.2 BioLegend Business Overview
11.2.3 BioLegend Neuroscience Antibodies and Assays Technology Introduction
11.2.4 BioLegend Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.2.5 BioLegend Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Neuroscience Antibodies and Assays Technology Introduction
11.3.4 Siemens Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.3.5 Siemens Recent Development
11.4 Bio-Rad
11.4.1 Bio-Rad Company Details
11.4.2 Bio-Rad Business Overview
11.4.3 Bio-Rad Neuroscience Antibodies and Assays Technology Introduction
11.4.4 Bio-Rad Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.4.5 Bio-Rad Recent Development
11.5 Genscript Biotech
11.5.1 Genscript Biotech Company Details
11.5.2 Genscript Biotech Business Overview
11.5.3 Genscript Biotech Neuroscience Antibodies and Assays Technology Introduction
11.5.4 Genscript Biotech Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.5.5 Genscript Biotech Recent Development
11.6 Rockland Immunochemicals
11.6.1 Rockland Immunochemicals Company Details
11.6.2 Rockland Immunochemicals Business Overview
11.6.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Technology Introduction
11.6.4 Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.6.5 Rockland Immunochemicals Recent Development
11.7 Cell Signaling Technology
11.7.1 Cell Signaling Technology Company Details
11.7.2 Cell Signaling Technology Business Overview
11.7.3 Cell Signaling Technology Neuroscience Antibodies and Assays Technology Introduction
11.7.4 Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.7.5 Cell Signaling Technology Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Neuroscience Antibodies and Assays Technology Introduction
11.8.4 Merck Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.8.5 Merck Recent Development
11.9 Tecan Group
11.9.1 Tecan Group Company Details
11.9.2 Tecan Group Business Overview
11.9.3 Tecan Group Neuroscience Antibodies and Assays Technology Introduction
11.9.4 Tecan Group Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.9.5 Tecan Group Recent Development
11.10 Santa Cruz Biotechnology
11.10.1 Santa Cruz Biotechnology Company Details
11.10.2 Santa Cruz Biotechnology Business Overview
11.10.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Technology Introduction
11.10.4 Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.10.5 Santa Cruz Biotechnology Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Neuroscience Antibodies and Assays Technology Introduction
11.11.4 Thermo Fisher Scientific Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Enzo Life Sciences
11.12.1 Enzo Life Sciences Company Details
11.12.2 Enzo Life Sciences Business Overview
11.12.3 Enzo Life Sciences Neuroscience Antibodies and Assays Technology Introduction
11.12.4 Enzo Life Sciences Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025)
11.12.5 Enzo Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Molecular Diagnostics
Table 3. Key Players of Clinical Chemistry
Table 4. Key Players of Immunoassay
Table 5. Key Players of Immunochemistry
Table 6. Key Players of Others
Table 7. Global Neuroscience Antibodies and Assays Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Neuroscience Antibodies and Assays Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Neuroscience Antibodies and Assays Technology Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Neuroscience Antibodies and Assays Technology Market Share by Region (2020-2025)
Table 11. Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Neuroscience Antibodies and Assays Technology Market Share by Region (2026-2031)
Table 13. Neuroscience Antibodies and Assays Technology Market Trends
Table 14. Neuroscience Antibodies and Assays Technology Market Drivers
Table 15. Neuroscience Antibodies and Assays Technology Market Challenges
Table 16. Neuroscience Antibodies and Assays Technology Market Restraints
Table 17. Global Neuroscience Antibodies and Assays Technology Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Neuroscience Antibodies and Assays Technology Market Share by Players (2020-2025)
Table 19. Global Top Neuroscience Antibodies and Assays Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays Technology as of 2024)
Table 20. Ranking of Global Top Neuroscience Antibodies and Assays Technology Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Neuroscience Antibodies and Assays Technology Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Neuroscience Antibodies and Assays Technology, Headquarters and Area Served
Table 23. Global Key Players of Neuroscience Antibodies and Assays Technology, Product and Application
Table 24. Global Key Players of Neuroscience Antibodies and Assays Technology, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neuroscience Antibodies and Assays Technology Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Type (2020-2025)
Table 28. Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Type (2026-2031)
Table 30. Global Neuroscience Antibodies and Assays Technology Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Application (2020-2025)
Table 32. Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Application (2026-2031)
Table 34. North America Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031) & (US$ Million)
Table 49. Abcam Company Details
Table 50. Abcam Business Overview
Table 51. Abcam Neuroscience Antibodies and Assays Technology Product
Table 52. Abcam Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 53. Abcam Recent Development
Table 54. BioLegend Company Details
Table 55. BioLegend Business Overview
Table 56. BioLegend Neuroscience Antibodies and Assays Technology Product
Table 57. BioLegend Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 58. BioLegend Recent Development
Table 59. Siemens Company Details
Table 60. Siemens Business Overview
Table 61. Siemens Neuroscience Antibodies and Assays Technology Product
Table 62. Siemens Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 63. Siemens Recent Development
Table 64. Bio-Rad Company Details
Table 65. Bio-Rad Business Overview
Table 66. Bio-Rad Neuroscience Antibodies and Assays Technology Product
Table 67. Bio-Rad Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 68. Bio-Rad Recent Development
Table 69. Genscript Biotech Company Details
Table 70. Genscript Biotech Business Overview
Table 71. Genscript Biotech Neuroscience Antibodies and Assays Technology Product
Table 72. Genscript Biotech Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 73. Genscript Biotech Recent Development
Table 74. Rockland Immunochemicals Company Details
Table 75. Rockland Immunochemicals Business Overview
Table 76. Rockland Immunochemicals Neuroscience Antibodies and Assays Technology Product
Table 77. Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 78. Rockland Immunochemicals Recent Development
Table 79. Cell Signaling Technology Company Details
Table 80. Cell Signaling Technology Business Overview
Table 81. Cell Signaling Technology Neuroscience Antibodies and Assays Technology Product
Table 82. Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 83. Cell Signaling Technology Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Neuroscience Antibodies and Assays Technology Product
Table 87. Merck Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 88. Merck Recent Development
Table 89. Tecan Group Company Details
Table 90. Tecan Group Business Overview
Table 91. Tecan Group Neuroscience Antibodies and Assays Technology Product
Table 92. Tecan Group Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 93. Tecan Group Recent Development
Table 94. Santa Cruz Biotechnology Company Details
Table 95. Santa Cruz Biotechnology Business Overview
Table 96. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Technology Product
Table 97. Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 98. Santa Cruz Biotechnology Recent Development
Table 99. Thermo Fisher Scientific Company Details
Table 100. Thermo Fisher Scientific Business Overview
Table 101. Thermo Fisher Scientific Neuroscience Antibodies and Assays Technology Product
Table 102. Thermo Fisher Scientific Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 103. Thermo Fisher Scientific Recent Development
Table 104. Enzo Life Sciences Company Details
Table 105. Enzo Life Sciences Business Overview
Table 106. Enzo Life Sciences Neuroscience Antibodies and Assays Technology Product
Table 107. Enzo Life Sciences Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 108. Enzo Life Sciences Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
Table 112. Authors List of This Report
List of Figures
Figure 1. Neuroscience Antibodies and Assays Technology Picture
Figure 2. Global Neuroscience Antibodies and Assays Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neuroscience Antibodies and Assays Technology Market Share by Type: 2024 VS 2031
Figure 4. Molecular Diagnostics Features
Figure 5. Clinical Chemistry Features
Figure 6. Immunoassay Features
Figure 7. Immunochemistry Features
Figure 8. Others Features
Figure 9. Global Neuroscience Antibodies and Assays Technology Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Neuroscience Antibodies and Assays Technology Market Share by Application: 2024 VS 2031
Figure 11. Hospitals Case Studies
Figure 12. Diagnostics Center Case Studies
Figure 13. Pharmaceutical and Biotechnology Company Case Studies
Figure 14. Others Case Studies
Figure 15. Neuroscience Antibodies and Assays Technology Report Years Considered
Figure 16. Global Neuroscience Antibodies and Assays Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Neuroscience Antibodies and Assays Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Neuroscience Antibodies and Assays Technology Market Share by Region: 2024 VS 2031
Figure 19. Global Neuroscience Antibodies and Assays Technology Market Share by Players in 2024
Figure 20. Global Top Neuroscience Antibodies and Assays Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays Technology as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Neuroscience Antibodies and Assays Technology Revenue in 2024
Figure 22. North America Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Neuroscience Antibodies and Assays Technology Market Share by Country (2020-2031)
Figure 24. United States Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Neuroscience Antibodies and Assays Technology Market Share by Country (2020-2031)
Figure 28. Germany Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Share by Region (2020-2031)
Figure 36. China Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Neuroscience Antibodies and Assays Technology Market Share by Country (2020-2031)
Figure 44. Mexico Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Share by Country (2020-2031)
Figure 48. Turkey Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Abcam Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 52. BioLegend Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 53. Siemens Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 54. Bio-Rad Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 55. Genscript Biotech Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 56. Rockland Immunochemicals Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 57. Cell Signaling Technology Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 58. Merck Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 59. Tecan Group Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 60. Santa Cruz Biotechnology Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 62. Enzo Life Sciences Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Molecular Diagnostics
Table 3. Key Players of Clinical Chemistry
Table 4. Key Players of Immunoassay
Table 5. Key Players of Immunochemistry
Table 6. Key Players of Others
Table 7. Global Neuroscience Antibodies and Assays Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Neuroscience Antibodies and Assays Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Neuroscience Antibodies and Assays Technology Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Neuroscience Antibodies and Assays Technology Market Share by Region (2020-2025)
Table 11. Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Neuroscience Antibodies and Assays Technology Market Share by Region (2026-2031)
Table 13. Neuroscience Antibodies and Assays Technology Market Trends
Table 14. Neuroscience Antibodies and Assays Technology Market Drivers
Table 15. Neuroscience Antibodies and Assays Technology Market Challenges
Table 16. Neuroscience Antibodies and Assays Technology Market Restraints
Table 17. Global Neuroscience Antibodies and Assays Technology Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Neuroscience Antibodies and Assays Technology Market Share by Players (2020-2025)
Table 19. Global Top Neuroscience Antibodies and Assays Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays Technology as of 2024)
Table 20. Ranking of Global Top Neuroscience Antibodies and Assays Technology Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Neuroscience Antibodies and Assays Technology Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Neuroscience Antibodies and Assays Technology, Headquarters and Area Served
Table 23. Global Key Players of Neuroscience Antibodies and Assays Technology, Product and Application
Table 24. Global Key Players of Neuroscience Antibodies and Assays Technology, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neuroscience Antibodies and Assays Technology Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Type (2020-2025)
Table 28. Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Type (2026-2031)
Table 30. Global Neuroscience Antibodies and Assays Technology Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Application (2020-2025)
Table 32. Global Neuroscience Antibodies and Assays Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Neuroscience Antibodies and Assays Technology Revenue Market Share by Application (2026-2031)
Table 34. North America Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size by Country (2026-2031) & (US$ Million)
Table 49. Abcam Company Details
Table 50. Abcam Business Overview
Table 51. Abcam Neuroscience Antibodies and Assays Technology Product
Table 52. Abcam Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 53. Abcam Recent Development
Table 54. BioLegend Company Details
Table 55. BioLegend Business Overview
Table 56. BioLegend Neuroscience Antibodies and Assays Technology Product
Table 57. BioLegend Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 58. BioLegend Recent Development
Table 59. Siemens Company Details
Table 60. Siemens Business Overview
Table 61. Siemens Neuroscience Antibodies and Assays Technology Product
Table 62. Siemens Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 63. Siemens Recent Development
Table 64. Bio-Rad Company Details
Table 65. Bio-Rad Business Overview
Table 66. Bio-Rad Neuroscience Antibodies and Assays Technology Product
Table 67. Bio-Rad Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 68. Bio-Rad Recent Development
Table 69. Genscript Biotech Company Details
Table 70. Genscript Biotech Business Overview
Table 71. Genscript Biotech Neuroscience Antibodies and Assays Technology Product
Table 72. Genscript Biotech Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 73. Genscript Biotech Recent Development
Table 74. Rockland Immunochemicals Company Details
Table 75. Rockland Immunochemicals Business Overview
Table 76. Rockland Immunochemicals Neuroscience Antibodies and Assays Technology Product
Table 77. Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 78. Rockland Immunochemicals Recent Development
Table 79. Cell Signaling Technology Company Details
Table 80. Cell Signaling Technology Business Overview
Table 81. Cell Signaling Technology Neuroscience Antibodies and Assays Technology Product
Table 82. Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 83. Cell Signaling Technology Recent Development
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Neuroscience Antibodies and Assays Technology Product
Table 87. Merck Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 88. Merck Recent Development
Table 89. Tecan Group Company Details
Table 90. Tecan Group Business Overview
Table 91. Tecan Group Neuroscience Antibodies and Assays Technology Product
Table 92. Tecan Group Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 93. Tecan Group Recent Development
Table 94. Santa Cruz Biotechnology Company Details
Table 95. Santa Cruz Biotechnology Business Overview
Table 96. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Technology Product
Table 97. Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 98. Santa Cruz Biotechnology Recent Development
Table 99. Thermo Fisher Scientific Company Details
Table 100. Thermo Fisher Scientific Business Overview
Table 101. Thermo Fisher Scientific Neuroscience Antibodies and Assays Technology Product
Table 102. Thermo Fisher Scientific Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 103. Thermo Fisher Scientific Recent Development
Table 104. Enzo Life Sciences Company Details
Table 105. Enzo Life Sciences Business Overview
Table 106. Enzo Life Sciences Neuroscience Antibodies and Assays Technology Product
Table 107. Enzo Life Sciences Revenue in Neuroscience Antibodies and Assays Technology Business (2020-2025) & (US$ Million)
Table 108. Enzo Life Sciences Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
Table 112. Authors List of This Report
List of Figures
Figure 1. Neuroscience Antibodies and Assays Technology Picture
Figure 2. Global Neuroscience Antibodies and Assays Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neuroscience Antibodies and Assays Technology Market Share by Type: 2024 VS 2031
Figure 4. Molecular Diagnostics Features
Figure 5. Clinical Chemistry Features
Figure 6. Immunoassay Features
Figure 7. Immunochemistry Features
Figure 8. Others Features
Figure 9. Global Neuroscience Antibodies and Assays Technology Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Neuroscience Antibodies and Assays Technology Market Share by Application: 2024 VS 2031
Figure 11. Hospitals Case Studies
Figure 12. Diagnostics Center Case Studies
Figure 13. Pharmaceutical and Biotechnology Company Case Studies
Figure 14. Others Case Studies
Figure 15. Neuroscience Antibodies and Assays Technology Report Years Considered
Figure 16. Global Neuroscience Antibodies and Assays Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Neuroscience Antibodies and Assays Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Neuroscience Antibodies and Assays Technology Market Share by Region: 2024 VS 2031
Figure 19. Global Neuroscience Antibodies and Assays Technology Market Share by Players in 2024
Figure 20. Global Top Neuroscience Antibodies and Assays Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays Technology as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Neuroscience Antibodies and Assays Technology Revenue in 2024
Figure 22. North America Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Neuroscience Antibodies and Assays Technology Market Share by Country (2020-2031)
Figure 24. United States Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Neuroscience Antibodies and Assays Technology Market Share by Country (2020-2031)
Figure 28. Germany Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Neuroscience Antibodies and Assays Technology Market Share by Region (2020-2031)
Figure 36. China Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Neuroscience Antibodies and Assays Technology Market Share by Country (2020-2031)
Figure 44. Mexico Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Neuroscience Antibodies and Assays Technology Market Share by Country (2020-2031)
Figure 48. Turkey Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Neuroscience Antibodies and Assays Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Abcam Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 52. BioLegend Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 53. Siemens Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 54. Bio-Rad Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 55. Genscript Biotech Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 56. Rockland Immunochemicals Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 57. Cell Signaling Technology Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 58. Merck Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 59. Tecan Group Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 60. Santa Cruz Biotechnology Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 62. Enzo Life Sciences Revenue Growth Rate in Neuroscience Antibodies and Assays Technology Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232